Johnson & Johnson Innovation – JJDC participated in a round that boosted the total raised by the hair loss, migraine and acid reflux treatment provider to $70m.
Digital healthcare provider Thirty Madison has secured $47m in series B funding from investors including medical group Johnson & Johnson’s corporate venturing unit, Johnson & Johnson Innovation – JJDC.
Healthcare technology investment firm Polaris Partners led the round, which also featured venture capital firms Maveron and Northzone. Amy Schulman, managing partner at Polaris, will take a board seat at the company in conjunction with the round.
Thirty Madison runs a digital health service that combines online consultations, home delivery for…
